Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Post-transplant Patients”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05901194
What this trial is testing

Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Not applicableActive Not RecruitingNCT06304467
What this trial is testing

CM for Patients With ALD After Liver Transplant

Who this might be right for
Alcohol Use DisorderAlcohol; LiverPost Liver Transplant+2 more
Arpan A. Patel, MD 30
Testing effectiveness (Phase 2)Ended earlyNCT00228592
What this trial is testing

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Who this might be right for
Hepatitis BLiver Transplantation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Not applicableStudy completedNCT06114251
What this trial is testing

Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular Carcinoma

Who this might be right for
Liver Transplant; Complications
Zhejiang University 920
Large-scale testing (Phase 3)Study completedNCT00838071
What this trial is testing

Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation

Who this might be right for
Hepatitis B, Chronic
Instituto Grifols, S.A. 20
Not applicableEnrolling By InvitationNCT03930810
What this trial is testing

NAtural Course and Prognosis of PFIC and Effect of Biliary Diversion

Who this might be right for
Progressive Familial Intrahepatic Cholestasis
University Medical Center Groningen 1,500
Not applicableUnknownNCT01664780
What this trial is testing

Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation

Who this might be right for
Liver Transplantation
University of Erlangen-Nürnberg Medical School 100
Not applicableUnknownNCT03603548
What this trial is testing

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Who this might be right for
Liver Transplant RejectionImmunosuppression
Medical University of Warsaw 200
Not applicableStudy completedNCT04963309
What this trial is testing

Extubation in the Operating Room After Living Donor Liver Transplantation

Who this might be right for
Extubation in the OR After LDLT
Pusan National University Yangsan Hospital 277
Not applicableUnknownNCT04295928
What this trial is testing

Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

Who this might be right for
Personalized Pharmaceutical Plan After Transpantation
University Hospital, Tours 1,716
Large-scale testing (Phase 3)Study completedNCT01571583
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
Janssen-Cilag International NV 74
Not applicableUnknownNCT04754503
What this trial is testing

Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over

Who this might be right for
Patients Suitable for a Liver Transplant
Gérond'if 125
Early research (Phase 1)Study completedNCT01888302
What this trial is testing

Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery

Who this might be right for
Hepatic Complication
Mayo Clinic 1
Early research (Phase 1)Study completedNCT00997022
What this trial is testing

Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients

Who this might be right for
Hepatocellular Cancer
Columbia University 14
Not applicableLooking for participantsNCT05326399
What this trial is testing

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

Who this might be right for
Liver TransplantationRenal Insufficiency, Chronic
RenJi Hospital 369
Not applicableStudy completedNCT02057484
What this trial is testing

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

Who this might be right for
Liver TransplantKidney Transplant
Astellas Pharma Europe Ltd. 2,300
Not applicableUnknownNCT05411926
What this trial is testing

Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAcute Rejection
Beijing Tsinghua Chang Gung Hospital 30
Not applicableUnknownNCT05879328
What this trial is testing

The ImmunoXXL Study

Who this might be right for
Hepatocellular Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 12
Load More Results